Phase IIIb Clinical Trial of Quadrivalent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) for Age/Immunization Schedule Bridging
National Vaccine and Serum Institute, China
National Vaccine and Serum Institute, China
Hyperfine
ModernaTX, Inc.
Pfizer
Celgene
GlaxoSmithKline
AION Biosystems
Avita Medical
Atara Biotherapeutics
Shandong Branden Med.Device Co.,Ltd
Celgene
Celgene
Celgene
AlloVir
GlaxoSmithKline
X4 Pharmaceuticals
Cellerant Therapeutics
Merck Sharp & Dohme LLC
Enzon Pharmaceuticals, Inc.
Sanofi
Eli Lilly and Company